Below, we focus on inhibitory checkpoints regulated by PD-1/PD-L1, CTLA-4, and CD47 that suppress innate and adaptive immune cells including APCs and effector T cells that orchestrate tumor immunity (Figure 1). Here, CTLA4 is linked to neoplasm.